Arthur Fratamico - Net Worth and Insider Trading
Arthur Fratamico Net Worth
The estimated net worth of Arthur Fratamico is at least $210,000 dollars as of 2024-06-13. Arthur Fratamico is the Chief Business Officer of Vitae Pharmaceuticals Inc and owns about 10,000 shares of Vitae Pharmaceuticals Inc (VTAE) stock worth over $210,000. Details can be seen in Arthur Fratamico's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arthur Fratamico has not made any transactions after 2015-08-27 and currently still holds the listed stock(s).
Transaction Summary of Arthur Fratamico
Arthur Fratamico Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arthur Fratamico owns 4 companies in total, including Panbela Therapeutics Inc (PBLA) , Galera Therapeutics Inc (GRTX) , and Vitae Pharmaceuticals Inc (VTAE) among others .
Click here to see the complete history of Arthur Fratamico’s form 4 insider trades.
Insider Ownership Summary of Arthur Fratamico
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PBLA | Panbela Therapeutics Inc | 2019-12-16 | director |
| GRTX | Galera Therapeutics Inc | 2019-11-06 | Chief Business Officer |
| VTAE | Vitae Pharmaceuticals Inc | 2016-10-24 | Chief Business Officer |
 | | 2014-02-11 | Chief Business Officer |
Arthur Fratamico Latest Holdings Summary
Arthur Fratamico currently owns a total of 1 stock. Arthur Fratamico owns 10,000 shares of Vitae Pharmaceuticals Inc (VTAE) as of August 27, 2015, with a value of $210,000.
Latest Holdings of Arthur Fratamico
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VTAE | Vitae Pharmaceuticals Inc | 2015-08-27 | 10,000 | 21.00 | 210,000 |
Holding Weightings of Arthur Fratamico
Arthur Fratamico Form 4 Trading Tracker
According to the SEC Form 4 filings, Arthur Fratamico has made a total of 0 transactions in Vitae Pharmaceuticals Inc (VTAE) over the past 5 years. The most-recent trade in Vitae Pharmaceuticals Inc is the acquisition of 10,000 shares on August 27, 2015, which cost Arthur Fratamico around $78,300.
Insider Trading History of Arthur Fratamico
- 1
Arthur Fratamico Trading Performance
GuruFocus tracks the stock performance after each of Arthur Fratamico's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur Fratamico is 83.86%. GuruFocus also compares Arthur Fratamico's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur Fratamico within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arthur Fratamico's insider trading performs compared to the benchmark.
Performance of Arthur Fratamico
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 82.08 | | | | | |
| Relative Return to S&P 500(%) | 84.91 | | | | | |
Arthur Fratamico Ownership Network
Arthur Fratamico Owned Company Details
What does Panbela Therapeutics Inc do?
Who are the key executives at Panbela Therapeutics Inc?
Arthur Fratamico is the director of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include director & President and CEO Jennifer K. Simpson , V.P. of Finance & CFO Susan Horvath , and 10 percent owner Ryan Randall Gilbertson .
Panbela Therapeutics Inc (PBLA) Insider Trades Summary
Over the past 18 months, Arthur Fratamico made no insider transaction in Panbela Therapeutics Inc (PBLA). Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc , a net purchase of 4,444 shares made by Susan Horvath , and a net purchase of 4,444 shares made by Jennifer K. Simpson .
In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 15 shares were bought by its insiders, resulting in a net sale of 3,629 shares.
Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Panbela Therapeutics Inc Insider Transactions
Arthur Fratamico Mailing Address
Above is the net worth, insider trading, and ownership report for Arthur Fratamico. You might contact Arthur Fratamico via mailing address: C/o Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
